返回
CellaVision AB (CVLLY) 收益
CVLLY 股价走势图
CVLLY 收益
CellaVision AB
CN¥9.04
0%
$0
收盘价：Mar 24, 16:00:00 GMT-4
CN¥9.04
0%
$0
盘后：Mar 24, 16:43:30 GMT-4
关键数据
前收盘价
$9.04
开盘价
$8.75
当日区间
$8.75 - $9.04
52周范围
$8.75 - $9.04
交易量
100
平均成交量
8
股息收益率
--
每股收益（TTM）
0.34
市值
$215.6M
什么是 CVLLY？
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 236 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.